Topical Ammonia-Oxidizing Bacteria for Acne Without Antibiotic Risks
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for acne are either marginally effective or associated with serious risks, and there is a need for a safe, non-toxic, and effective topical therapy that can reduce acne severity, inflammation, and excess sebum production while preventing antibiotic resistance.
Innovation Solution
The use of ammonia oxidizing bacteria, such as Nitrosomonas eutropha, is applied topically to reduce pathogenic bacteria like Propionibacterium acnes, inflammation, and sebum production, and to improve skin condition and quality of life.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional acne treatments (oral antibiotics, topical antibiotics, retinoids) are used, then acne severity is reduced, but serious risks and side effects occur
Solution Approach 1:
The patent introduces ammonia-oxidizing bacteria as an intermediary organism that indirectly treats acne by consuming ammonia produced by P. acnes bacteria, rather than directly killing the pathogenic bacteria. This mediator approach reduces the harmful side effects associated with direct antibiotic and retinoid treatments while maintaining treatment effectiveness.
Solution Approach 2:
The patent converts the harmful ammonia byproduct produced by P. acnes into a beneficial target for treatment. By introducing ammonia-oxidizing bacteria that consume this ammonia, the treatment transforms the pathogenic bacteria's waste product into a mechanism for controlling acne, avoiding the need for toxic antibiotics and retinoids.
2Reliability
If topical antibiotics are used, then acne lesions are treated, but antibiotic resistance develops
Solution Approach 1:
The patent converts the ammonia byproduct of P. acnes into a therapeutic target. By using ammonia-oxidizing bacteria to consume ammonia rather than antibiotics to kill bacteria, the treatment avoids selecting for antibiotic-resistant strains while effectively controlling acne lesions.
Solution Approach 2:
The patent uses ammonia-oxidizing bacteria as an intermediary that targets a metabolic byproduct (ammonia) rather than the pathogenic bacteria directly. This indirect approach eliminates the selective pressure that drives antibiotic resistance while maintaining treatment effectiveness.
3Reliability
If oral retinoids are used, then severe acne is treated, but teratogenic effects and serious risks occur
Solution Approach 1:
The patent introduces ammonia-oxidizing bacteria as a safe intermediary treatment that can be used for severe acne without the teratogenic risks of oral retinoids. The bacteria consume ammonia locally on the skin, providing effective treatment without systemic absorption and fetal exposure risks.
Solution Approach 2:
The patent provides a safe alternative for severe acne treatment by targeting ammonia metabolism rather than using teratogenic retinoids. This approach converts the harmful ammonia byproduct into a controllable parameter without exposing pregnant or planning patients to teratogenic effects.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The application of ammonia oxidizing bacteria effectively decreases Propionibacterium acnes, reduces acne severity, inflammation, and sebum production, and improves skin condition and quality of life without the risks associated with traditional treatments.
Implementation Method 1
ammonia oxidizing bacteria, e.g., a preparation comprising ammonia oxidizing bacteria
Data Source
AI summary
A method for treating a skin disorder, e.g., acne, e.g. acne vulgaris, in a subject is provided. The method comprises administering, e.g., applying, e.g., topically administering, ammonia oxidizing bacteria, e.g., a preparation comprising ammonia oxidizing bacteria, to a surface of the subject. Preparations comprising ammonia oxidizing bacteria for treating such skin disorder, e.g., acne, e.g. acne vulgaris in a subject are also provided.